Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00025025 · ClinicalTrials.gov registry record
Screening Tests in Detecting Colorectal Cancer
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 4,482
- Enrollment target
NCT00025025: Completed study, sponsored by Alliance for Clinical Trials in Oncology.
NCT00025025 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 4,482 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00025025 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 4,482 participants
- Enrollment target
Study Summary
RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for colorectal cancer. PURPOSE: Randomized screening trial to compare the effectiveness of fecal occult blood testing with that of DNA-based testing of stool and blood in identifying colorectal cancer.
Interventions
- OTHER sample testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,482 participants |
| Start Date | 2001-10 |
| Est. Completion | 2009-06 |
What the finished NCT00025025 record still lists
NCT00025025 is an observational study that tracks outcomes without assigning an intervention. Its 4,482 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which sample testing is the first listed.
NCT00025025 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00025025 about?
NCT00025025 is a clinical study titled "Screening Tests in Detecting Colorectal Cancer". RATIONALE: Screening tests may help doctors detect cancer cells early and plan more effective treatment for colorectal cancer. PURPOSE: Randomized screening trial to compare the effectiveness of fecal occult blood testing with that of DNA-based testing of stool and blood in identifying colorectal c...
What is the current status of trial NCT00025025?
This trial is currently completed. The enrollment target is 4,482 participants. The study started on 2001-10. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00025025?
The interventions under investigation include: sample testing (OTHER).
Who is sponsoring clinical trial NCT00025025?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06252753 · 4,490 participants
Observational Study Protocol: LIVER-R
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
- NCT06588452 · 4,500 participants
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
- NCT07165028 · 4,500 participants · Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia